TAG:
molecular pathology
Quest Bites: Will Pay $2 Billion for AmeriPath
By Robert Michel | From the Volume XIV No. 6 – April 23, 2007 Issue
CEO SUMMARY: From its inception in the mid-1990s as a pathology physician practice management (PPM) company, AmeriPath was a business that its investors created specifically to be sold. Now Quest Diagnostics Incorporated is stepping up to pay a princely ransom of $2 billion to make AmeriP…
Anatomic Pathology’s Coming Revolution: Same Day Diagnoses
By Robert Michel | From the Volume XIV No. 5 – April 2, 2007 Issue
CEO SUMMARY: Anatomic pathology has been conducted the same way for 100 years—but no longer at the University of Miami. Pathologists there are using microwave technology to cut processing speed by 90% and improve workflow. By producing faster diagnoses, the lab can report results on 80%…
Newspaper Reports Miss on Molecular Technology
By Robert Michel | From the Volume XIV No. 5 – April 2, 2007 Issue
CEO SUMMARY: In reporting on a suspected outbreak of whooping cough (Bordetella pertussis), a national newspaper suggested administrators at Dartmouth Hitchcock Medical Center had placed too much faith in molecular testing. In this exclusive interview, Dartmouth’s Director of Molecular …
LIS As Productivity Tool Throughout the Laboratory
By Robert Michel | From the Volume XVI No. 3 – February 19, 2007 Issue
CEO SUMMARY: Is the classic laboratory information system (LIS) morphing into a different information technology product? That’s the observation of one laboratory IT expert, who says that “best of breed” LIS products are becoming productivity tools that support improved clinical per…
Whooping Cough Cases Reveal Test Deficiencies
By Robert Michel | From the Volume XVI No. 3 – February 19, 2007 Issue
CEO SUMMARY: Doctors rely on labs for the definitive diagnosis of the bacterium that causes whooping cough. Yet in several recent cases, the use of a molecular test for a definitive diagnosis led to questions about the effectiveness of the test. Molecular pathologists recommend labs may n…
Key Trends Drive Change for Clinical Laboratories
By Robert Michel | From the Volume XIV No. 1 – January 8, 2007 Issue
CEO SUMMARY: Technology plays an ever-growing role in reshaping the organization and operation of clinical laboratories. New technologies figure prominently in THE DARK REPORT’S 2007 list of key trends in the clinical laboratory industry. Technological advances in instr…
Good News for Regional Labs Competing Against Nationals
By Robert Michel | From the Volume XIII No. 8 – June 12, 2006 Issue
CAN REGIONAL LABORATORIES compete effectively against the two blood brothers? This question lies at the heart of the business strategy for most hospital laboratory outreach programs in the United States. After all, in their community, the toughest competitors they face are likely to be Quest…
Many Trends in AP Spell Lots of Change Ahead
By Robert Michel | From the Volume XIII No. 2 – February 6, 2006 Issue
CEO SUMMARY: Every second year, THE DARK REPORT releases its list of key trends in anatomic pathology. These trends help shape an understanding about the state of the pathology profession. Our current list includes 11 identifiable trends. This is not an auspicious sign for pathologists wh…
For Molecular Tests, Evaluate All Factors
By Robert Michel | From the Volume XII No. 8 – May 30, 2005 Issue
CEO SUMMARY: When this hospital lab adopted molecular screening tests for Chlamydia trachomatis and Neisseria gonorrhoaea, physicians soon noticed a change in the rate of false positives. In researching the performance of the molecular assays compared to cultures, pathologists at this lab…
ASCP’s “Molecular Pathology” Certification Now Available
RECOGNIZING the growing importance of molecular pathology, the American Society of Clinical Pathology (ASCP) established a new certification program in this diagnostic specialty. Offered since June 2003, 18 people have passed the examination and can use the designation “MP (ASCP)….
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized